Erin Duffy, Ph. D., is the R&D chief of CARB-X, a global partnership led by Boston University that is accelerating innovation in the discovery and early development of therapeutics, preventatives and diagnostics to combat drug-resistant bacteria. She has 17+ years of drug-discovery and problem-solving experience in the antibiotic arena, having led the research efforts at Melinta Therapeutics (fka Rib-X Pharmaceuticals) , ultimately as the Chief Scientific Officer. Erin began her scientific career as a computational chemist with Pfizer Central Research. She was trained formally as a physical-organic chemist and structural biologist at Yale University.